Dose effect analysis of sodium zirconium cyclosilicate in hemodialysis patients

被引：3
|
作者：
Spinowitz, Bruce [1 ]
McCafferty, Kieran [2 ]
Fishbane, Steven [3 ]
Fukagawa, Masafumi [4 ]
Guzman, Nicolas [5 ]
Ford, Martin [6 ,7 ]
Rastogi, Anjay [8 ]
Bhandari, Sunil [9 ]
机构：
[1] NewYork Presbyterian Queens, Dept Med, Queens, NY USA
[2] Barts Hlth NHS Trust, Dept Nephrol, London, England
[3] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Med, Great Neck, NY USA
[4] Tokai Univ, Sch Med, Dept Internal Med, Div Nephrol Endocrinol & Metab, Isehara, Kanagawa, Japan
[5] AstraZeneca BioPharmaceut Res & Dev, Global Med Dev, Gaithersburg, MD USA
[6] Kings Coll Hosp NHS Trust, Dept Renal Med, London, England
[7] Kings Coll London, Fac Life Sci & Med, London, England
[8] Univ Calif Los Angeles, UCLA CORE Kidney Program, Los Angeles, CA USA
[9] Hull Univ Teaching Hosp NHS Trust, Dept Renal & Transplant Med, Kingston Upon Hull, N Humberside, England
来源：
HEMODIALYSIS INTERNATIONAL | 2022年 / 26卷 / 02期
关键词：
dose; fluid balance; hemodialysis; hyperkalemia; potassium; sodium zirconium cyclosilicate;
D O I：
10.1111/hdi.12983
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：274 / 277
页数：4
相关论文
共 50 条
  • [21] An evaluation of sodium zirconium cyclosilicate: a new treatment option for hyperkalaemia in China
    Lu, Yuan
    Liu, Bi-Cheng
    Liu, Hong
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (03) : 301 - 308
  • [22] Impact of Sodium Zirconium Cyclosilicate Therapy Cessation in Patients with Systolic Heart Failure
    Imamura, Teruhiko
    Narang, Nikhil
    Kinugawa, Koichiro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (18)
  • [23] Effect of sodium zirconium cyclosilicate in combination with insulin and glucose infusion on hyperkalemia treatment
    Wu, Xuansheng
    Yue, Li
    Yin, Na
    Dai, Feng
    He, Fang
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (10) : 2217 - 2224
  • [24] Sodium Zirconium Cyclosilicate (Lokelma) for Hyperkalemia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1561): : 197 - 199
  • [25] Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease
    Nakayama, Takashin
    Yamaguchi, Shintaro
    Hayashi, Kaori
    Uchiyama, Kiyotaka
    Tajima, Takaya
    Azegami, Tatsuhiko
    Morimoto, Kohkichi
    Yoshida, Tadashi
    Yoshino, Jun
    Monkawa, Toshiaki
    Kanda, Takeshi
    Itoh, Hiroshi
    FRONTIERS IN MEDICINE, 2023, 10
  • [26] Sodium zirconium cyclosilicate-associated adverse events: An analysis of the FAERS database
    Lin, Yimin
    Hong, Qingxia
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2025,
  • [27] The effect of sodium zirconium cyclosilicate on acid-base balance in chronic kidney disease
    Mori, Daisuke
    Namiki, Yuta
    Sugimachi, Ayaka
    Kado, Manabu
    Tamai, Shinjiro
    Nomi, Hiroki
    Haga, Ryota
    Nagatoya, Katsuyuki
    Yamauchi, Atsushi
    CLINICAL NEPHROLOGY, 2022, 97 (05) : 255 - 260
  • [28] Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose–response, phase 2/3 study
    Naoki Kashihara
    Toshiki Nishio
    Takeshi Osonoi
    Yosuke Saka
    Toshiyuki Imasawa
    Takayasu Ohtake
    Hiroshi Mizuno
    Yugo Shibagaki
    Hyosung Kim
    Toshitaka Yajima
    Nobuaki Sarai
    Clinical and Experimental Nephrology, 2020, 24 : 1144 - 1153
  • [29] Population Pharmacodynamic Dose-Response Analysis of Serum Potassium Following Dosing with Sodium Zirconium Cyclosilicate
    Penland, Robert C.
    Astrand, Magnus
    Boulton, David W.
    Nagard, Mats
    CLINICAL PHARMACOKINETICS, 2024, 63 (04) : 551 - 560
  • [30] Effects of sodium zirconium cyclosilicate on sodium and potassium excretion in healthy adults: a Phase 1 study
    Nagard, Mats
    Singh, Bhupinder
    Boulton, David W.
    CLINICAL KIDNEY JOURNAL, 2021, 14 (08) : 1924 - 1931
12345